Bausch & Lomb Inc. plans in 2018 to launch the first US OTC ophthalmic solution containing brimonidine tartrate, emphasizing that it differs from the currently available nonprescription ingredient to relieve ocular redness by selectively constricting veins in the eye.
With market exclusivity for Lumify as the first OTC brimonidine eye drop, Bausch + Lomb likely will provide a significant...